Skip to Content

Join the 'Breast Cancer' group to help and get support from people like you.

Breast Cancer News

Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS

Clinical Trials Balance Out Urban, Rural Cancer Survival Rates

Posted 2 days ago by Drugs.com

FRIDAY, Aug. 17, 2018 – Differences in survival rates between rural and urban cancer patients may be due to the kind of care they receive, a review of cancer clinical trials contends. Research has shown that cancer patients in rural areas have lower survival rates than those in urban areas. For example, cancer death rates between 2011 and 2015 were 180 per 100,000 people in rural areas and 158 ...

Genetic Testing for Cancer Lacking for Women on Medicare: Study

Posted 2 days ago by Drugs.com

FRIDAY, Aug. 17, 2018 – Testing for gene mutations linked to breast and ovarian cancer is rare among some Medicare patients who have the cancers and qualify for such tests, a new study finds. Researchers analyzed data from 12 southeastern states between 2000 and 2014. Only 8 percent of 92 women who met Medicare criteria for BRCA1 and BRCA2 gene testing received it within five years of their ...

Breast Cancer Drug Promising in Phase 3 Trial

Posted 4 days ago by Drugs.com

WEDNESDAY, Aug. 15, 2018 – For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an experimental drug could improve survival, a new study suggests. The BRCA mutations are linked with a greater risk for aggressive breast and ovarian cancer. The drug, talazoparib, works by blocking an enzyme called poly ADP ribose polymerase (PARP), thus preventing cancer cells from ...

Gene Test Predicts Risk of 5 Common Diseases

Posted 5 days ago by Drugs.com

TUESDAY, Aug. 14, 2018 – A new type of genetic analysis could identify millions of Americans at high risk for five serious and common diseases, researchers report. The diseases include coronary artery disease, the heart rhythm disorder atrial fibrillation, type 2 diabetes, inflammatory bowel disease and breast cancer. Researchers tested and validated the genetic risk score on data from more ...

Lack of Exercise Can Boost Cancer Risk

Posted 6 days ago by Drugs.com

MONDAY, Aug. 13, 2018 – Few Americans know that inactivity can increase the risk of colon, breast and other types of cancer, a new study finds. An analysis of survey responses from 351 people revealed that while many knew a sedentary lifestyle increased their risk of heart disease (63.5 percent) and metabolic problems such as diabetes (65.8 percent), only 3.4 percent were aware it also adds to ...

Triple-Negative Breast Cancer Genes ID'd

Posted 11 days ago by Drugs.com

WEDNESDAY, Aug. 8, 2018 – More genes associated with an increased risk of triple-negative breast cancer have been identified by researchers. Until now, only mutations in the BRCA1 gene have been linked with this type of breast cancer. "Triple-negative breast cancer is an aggressive type of cancer that cannot be treated using targeted therapies," study leader Fergus Couch, a geneticist at the ...

Heart Monitoring a Must for Breast Cancer Patients on Herceptin

Posted 12 days ago by Drugs.com

TUESDAY, Aug. 7, 2018 – The widely used chemotherapy drug trastuzumab (Herceptin) can be life-saving for women with HER2-positive breast cancer, a particularly aggressive form of the disease. But new research now adds to mounting evidence that the treatment can take a toll on the heart, increasing the risk for heart failure. The complication is uncommon, and in many cases, the benefits of the ...

For Women Worldwide, Lung Cancers Rise as Breast Cancers Decline

Posted 18 days ago by Drugs.com

WEDNESDAY, Aug. 1, 2018 – As women around the world wage war against cancer, good news on the breast cancer front is tempered by predictions that lung cancer deaths could rise more than 40 percent. Researchers in Spain reported that between 2015 and 2030, lung cancer deaths among women worldwide will likely increase 43 percent. During that same period, however, breast cancer deaths are projected ...

3-Pronged Approach to Cancer Prevention

Posted 26 Jul 2018 by Drugs.com

THURSDAY, July 26, 2018 – Need another reason to improve your diet and start exercising? Doing so could help ward off cancer, a new study finds. "Keep in mind that every lifestyle factor counts and it is never too late to adopt a healthy lifestyle," said study co-author Bernard Srour, of the French National Institute of Health and Medical Research. Eating healthful foods, engaging in physical ...

Too Few Americans Getting Screened for Cancer: CDC

Posted 26 Jul 2018 by Drugs.com

THURSDAY, July 26, 2018 – Routine checks for breast, prostate, cervical and colon cancer save lives, but screening rates for all but colon cancer have stalled in recent years, U.S. health officials report. According to the new U.S. Centers for Disease Control and Prevention study, the number of Americans getting recommended cancer screening remains below target levels. This is especially the ...

Kisqali (ribociclib) Approved for Additional Indications in HR+/HER2- Advanced Breast Cancer

Posted 25 Jul 2018 by Drugs.com

Basel, July 18, 2018 - Novartis today announced a new approval for Kisqali (ribociclib) from the US Food and Drug Administration (FDA) for women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer. Kisqali is now the only CDK4/6 inhibitor indicated for use with an aromatase inhibitor for the treatment of pre-, peri- or ...

Many Struggle With High Cost of Breast Cancer Care

Posted 23 Jul 2018 by Drugs.com

MONDAY, July 23, 2018 – The cost of treatment for early stage breast cancer can be devastating for many patients, but they get little guidance or help from their doctors, a new study suggests. "We have made a lot of progress in breast cancer treatment, which is wonderful. But this study shows we are only part of the way to our goal. We must now turn our efforts to confronting the financial ...

Cancer Survival Drops With Complementary Therapy: Study

Posted 19 Jul 2018 by Drugs.com

THURSDAY, July 19, 2018 – People with curable cancers who try "complementary therapy" often refuse some part of standard care. And they may die as a result, researchers say. U.S. cancer patients increasingly use complementary medicine – a combination of standard care along with therapies that fall outside of mainstream medicine (such as acupuncture or massage). But little is known about the ...

Could an Early Supper Lower Breast, Prostate Cancer Risk?

Posted 18 Jul 2018 by Drugs.com

WEDNESDAY, July 18, 2018 – Having a late dinner and heading straight to bed may boost your risk of breast or prostate cancer, a new study suggests. Spanish researchers analyzed data from 621 prostate cancer patients and 1,205 breast cancer patients, as well as 872 men and 1,321 women without these cancers. People who ate their evening meal before 9 p.m. or waited at least two hours after supper ...

Health Tip: Travel Tips For Women With Breast Prosthesis

Posted 10 Jul 2018 by Drugs.com

-- After a mastectomy, many women prefer to wear a prosthesis, in lieu of reconstructive surgery. The prosthesis often is made of silicone gel or foam, and will be placed inside a bra or directly on a woman's chest. Sometimes. a prosthesis can pose difficulties when traveling by plane. The Susan G. Komen Foundation suggests: Get to the airport early so there is plenty of time to go through ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Breast Cancer - Male, Cancer

Related Drug Support Groups

methotrexate, fluorouracil, tamoxifen, Arimidex, Femara, anastrozole, letrozole, Xeloda, Herceptin, view more... Afinitor, Aromasin, exemestane, Taxol, Taxotere, Ibrance, Faslodex, capecitabine, Cytoxan, paclitaxel, gemcitabine, cyclophosphamide, Gemzar, esterified estrogens, everolimus, Menest, Abraxane, Verzenio, Kadcyla, bevacizumab, Adriamycin, eribulin, doxorubicin, Perjeta, nandrolone, Methotrexate LPF Sodium, Fareston, Nolvadex, pertuzumab, Neosar, Deca-Durabolin, Durabolin, Tykerb, vinblastine, trastuzumab, Velban, thiotepa, lapatinib, Kisqali, Ogivri, Hybolin-Improved, Halotestin, Hybolin Decanoate, Durabolin 50, Anabolin LA, Estratab, Androlone-D, Andryl 200, Ixempra, Adriamycin PFS, Tamosin, Halaven, Docefrez, Tepadina, Thioplex, aminoglutethimide, Tamoxifen Hexal, Cytadren, docetaxel, fluoxymesterone, fulvestrant, paclitaxel protein-bound, toremifene, ixabepilone, ado-trastuzumab emtansine, palbociclib, ribociclib, letrozole / ribociclib, abemaciclib, Adrucil, Tamoxen, Androxy, Trexall, Onxol, Soltamox, Cytoxan Lyophilized, Folex PFS, Adriamycin RDF, Tamone, Emblon, Tamofen, Nolvadex D, Genox, Infugem